Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C002202 |
4-oxoretinoic acid |
4-oxoretinoic acid results in decreased expression of KRT6A mRNA | decreases expression | 15982314
|
C103303 |
alitretinoin |
alitretinoin results in decreased expression of KRT6A mRNA | decreases expression | 15982314
|
D001151 |
Arsenic |
Arsenic results in increased expression of KRT6A mRNA | increases expression | 18414623
|
D001151 |
Arsenic |
Arsenic results in increased expression of KRT6A protein | increases expression | 18414623
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of KRT6A mRNA | increases expression | 15949261
|
D002104 |
Cadmium |
Cadmium results in increased expression of KRT6A mRNA | increases expression | 18414623
|
D002104 |
Cadmium |
Cadmium results in increased expression of KRT6A protein | increases expression | 18414623
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of KRT6A mRNA | increases expression | 16636312 15171707
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of KRT6A mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of KRT6A mRNA | increases expression | 19619570
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of KRT6A mRNA | affects cotreatment|increases expression | 17404688
|
D005472 |
Fluorouracil |
Fluorouracil affects the expression of KRT6A mRNA | affects expression | 16584549
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of KRT6A mRNA | affects cotreatment|increases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in increased expression of KRT6A mRNA | increases expression | 17404688
|
D015474 |
Isotretinoin |
Isotretinoin results in decreased expression of KRT6A mRNA | decreases expression | 15982314
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of KRT6A mRNA | increases expression | 12016162
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of KRT6A mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of KRT6A mRNA | increases expression | 16704738 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of KRT6A mRNA | increases expression | 17035482
|
D014212 |
Tretinoin |
Tretinoin metabolite results in decreased expression of KRT6A mRNA | decreases expression | 15982314
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of KRT6A mRNA | decreases expression | 15982314
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Isotretinoin |
9.09 | 18769834 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.09 | 14514962 15322242 11752688 |
MESH:D000015 |
Abnormalities, Multiple |
|
Isotretinoin |
5.06 | 18769834 |
MESH:D017486 |
Acneiform Eruptions |
|
Isotretinoin |
6.42 | 16232082 |
MESH:D000152 |
Acne Vulgaris |
|
Isotretinoin |
5.61 | 16185265 18769834 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
7.24 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
7.24 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
7.24 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.49 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.83 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
14.25 | 17306315 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
14.25 | 16712894 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.68 | 15955085 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.57 | 15469931 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.94 | 15504547 17963324 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.94 | 11748828 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.89 | 12569548 18414634 16251483 16835338 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.12 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.28 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.36 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
7.18 | 12928151 19371607 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
7.18 | 15687053 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.50 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
15.83 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.83 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
15.83 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.47 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.36 | 15665606 15380490 15845082 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
3.82 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
3.82 | 17129689 15324884 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.82 | 12948864 18497071 17289903 16675129 17261762 17018787 14630087 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
3.82 | 19217205 16595493 15136595 18608205 18357371 16110121 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
3.82 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.82 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
3.82 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.71 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.42 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.58 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.80 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.40 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.40 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.63 | 15504454 17687452 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.29 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
14.30 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
14.30 | 15553829 14691202 15073043 16217749 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
14.30 | 15948411 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
14.30 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
14.30 | 17971768 17045692 16799960 16332177 17088986 18930000 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
14.30 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
14.30 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.01 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.05 | 18695887 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.19 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
14.61 | 18922899 15504454 17687452 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
14.61 | 16280240 16757204 18986760 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Isotretinoin |
14.61 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
14.61 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
14.61 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.15 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.50 | 17938729 15738583 19152805 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.38 | 18022660 16973168 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.14 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
11.66 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
11.66 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
11.66 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.71 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.29 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.87 | 8697196 15668235 15340226 16354765 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.87 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.81 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.24 | 16340194 15001691 17172411 17725105 18772588 16510598 17018589 17016597 17169374 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.56 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.56 | 18509181 17094418 16331619 14970324 16282729 17255274 17401013 16391804 17695437 18288408 15148649 17016601 17454858 18949393 18448328 15289873 16303861 17594712 20501625 16524972 18383874 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.28 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
5.52 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Isotretinoin |
5.52 | 9879862 18769834 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.52 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
5.52 | 9125849 16925845 9211117 17551590 14991402 10589399 9142499 9664655 8800419 9224671 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
4.65 | 16002989 12952375 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.91 | 16733453 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.18 | 15213294 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.48 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.60 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.55 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.46 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.40 | 16714409 15322242 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.40 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.87 | 17692515 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
4.81 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
12.79 | 15700306 16804899 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
12.79 | 11473722 19148513 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
12.79 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.19 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.19 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.66 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.66 | 16481741 15173087 17638652 16785472 16337965 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.04 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.04 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
3.37 | 15073043 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.70 | 16002989 16513791 16534752 16611131 15751030 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.97 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.97 | 17994277 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.69 | 6392382 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.36 | 16904648 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
13.21 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
13.21 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.05 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.90 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.97 | 15102660 18337622 15162350 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.97 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.29 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.67 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.67 | 14991402 9664655 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.00 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.17 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.22 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.89 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 8697196 18606429 15340226 16354765 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.28 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.67 | 16778211 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.53 | 17050553 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
4.54 | 12960047 14722030 |
MESH:D006973 |
Hypertension |
|
Arsenic |
5.32 | 16076760 9931084 11953799 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.32 | 18850075 18670907 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.69 | 16093927 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
4.68 | 16002989 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.51 | 15869954 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
4.45 | 15036965 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.04 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.11 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.11 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.02 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.87 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.21 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.21 | 15992940 17551590 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.11 | 16930632 12749816 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.75 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
10.48 | 16962696 16322080 16226777 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
10.48 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
10.48 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
12.91 | 16762066 15003126 14681315 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
12.91 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
12.91 | 16985049 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
4.16 | 17184923 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.47 | 15070760 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.47 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.88 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.42 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.49 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
9.75 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.75 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.93 | 16467208 19850784 17050201 20471514 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.93 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
13.08 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
13.08 | 11468182 17217047 16891316 16331271 19035177 19225113 19642359 15336539 12712474 12018890 17712046 17649720 9834237 17869043 17107899 16330433 19075265 15622746 16112521 15748426 15213294 12679006 16823087 16966277 11161223 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
13.08 | 17649720 17301526 17712046 19029980 19075265 16140955 19642359 17506722 17361223 16788101 19035177 16331271 16823087 17368321 17294898 17217047 17339181 19225113 16891316 15748426 9834237 16935935 17107899 12679006 16766008 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.45 | 16882451 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.36 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.49 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.49 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.49 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.56 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
18.38 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
18.38 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
18.38 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
18.38 | 16603448 17045692 15113037 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
18.38 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
18.38 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
5.97 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.97 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.41 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.22 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
10.87 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
10.87 | 19168569 17306315 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
10.87 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
10.87 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Isotretinoin |
10.87 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
10.87 | 19931552 16712894 17077188 17306315 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
10.87 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.91 | 15086387 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
5.27 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
3.53 | 15700306 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.65 | 16002989 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.23 | 11408345 11807958 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.23 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.62 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.81 | 17453147 |
MESH:D008545 |
Melanoma |
|
Isotretinoin |
5.33 | 17237267 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.33 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.33 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.53 | 16940565 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.69 | 18986760 16757204 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.16 | 19549372 14977855 19417148 11468182 15949261 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.81 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.54 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.54 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
9.22 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.22 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.34 | 16810080 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.05 | 16624393 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
16.18 | 16946489 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
16.18 | 15313581 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
16.18 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
16.18 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
16.18 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.77 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.85 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
24.28 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
24.28 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
24.28 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
24.28 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
17.79 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
17.79 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
17.79 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
17.79 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Isotretinoin |
4.08 | 17368321 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.46 | 17056641 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.49 | 16436463 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
19.19 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
19.19 | 16624393 19769630 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
19.19 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
19.19 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
19.19 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
19.19 | 16936753 |
MESH:D053549 |
Pachyonychia Congenita |
marker/mechanism |
|
| |
MESH:D010146 |
Pain |
|
Tretinoin |
2.97 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
8.80 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
8.80 | 16929163 19003803 16500647 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.80 | 15976015 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.25 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.27 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
13.48 | 6392382 15371236 16905509 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
13.48 | 15687053 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
5.30 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.77 | 15687265 16977796 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
6.14 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
17.12 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Isotretinoin |
17.12 | 18769834 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
17.12 | 11399792 11118676 11222880 11896295 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.97 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.12 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.12 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.12 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
2.12 | 17136230 15046698 15846301 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.12 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.12 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.12 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
9.57 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
9.57 | 16636307 |
MESH:D011596 |
Psychomotor Disorders |
|
Isotretinoin |
6.03 | 18769834 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.91 | 16723453 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.08 | 18722050 16160472 15538739 18286688 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.19 | 16283617 16116481 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.88 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.05 | 16646077 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.76 | 16353154 16759981 19834688 15952646 17050553 17453740 6392382 17938729 18709164 17548696 16702368 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
13.88 | 17029826 15504454 17976673 19538983 16251483 17050553 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.88 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.88 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
13.88 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
4.85 | 16002989 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.40 | 15862959 16503802 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.86 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.44 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.44 | 16951190 19015929 19084572 18396642 17172411 17522103 15786421 16424979 18567086 17498489 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.44 | 17261132 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.42 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.42 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.82 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
10.09 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
10.09 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.08 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.27 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
12.23 | 17306315 11144890 19429237 17976673 18640142 19322015 15987713 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
12.23 | 11780464 20435036 12973940 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
12.23 | 16452187 16712894 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
12.23 | 17306315 16452187 16712894 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
23.29 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
23.29 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
23.29 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
23.29 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
5.30 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
4.16 | 15809267 16690809 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.74 | 16752155 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
4.54 | 16002989 16513791 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
12.24 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
12.24 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.15 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.04 | 16287080 |